About the blog

This is blog features a collection of short articles by V. Premnath.

The articles try to compile some of the thoughts, suggestions and ideas that I have shared with young people who have approached me for advise.

This blog is connected to the website, www.premnath.org

You can write to Premnath at v.premnath(at)ncl.res.in

Recent Posts

(19 April 2020) COVID19: Why diagnostics?

There is a lot of clamour about testing for COVID19. My view is that testing for testing sake is of no use. Every diagnostic test should provide an answer to a useful question being asked with a larger purpose in mind.

I thought I will use this blog to put down some useful purposes that testing can serve. (A disclaimer — there different types of diagnostic tests which answer different questions; so, please do not assume that every test does the same thing. Also different tests will have different levels of certainty with which they give results.)

Purposes for doing diagnostic tests for COVID19: 

  1. To support clinicians in their choice and sequence of therapy
    1. To identify if a patient has COVID19 to guide treatment
    2. To quantify viral load and severity
    3. To decide when to discharge the patient
  2. To guide R&D on drugs and vaccines
    1. To provide vital information and clues to R&D scientists on the progression of the disease
    2. To select candidates for clinical trials in a better manner so to come up with more meaningful results
    3. To quantitatively measure the impact of therapy
  3. To  support decisions of  public health authorities
    1. To identify those people who can spread the virus. To identify those who need to be quarantined.
    2. To identify those who can be allowed to leave quarantine
    3. To get better insights into who is more vulnerable and therefore should be protected
    4. To screen travellers and migrants at the borders for potential risks
  4. To provide important data (especially, as basis for assumptions and cross checking if the model predicts reality accurately) for mathematical models that are used to support decisions of the Government such as
    1. Imposing lockdowns
      1. When?
      2. Where?
    2. Lifting lockdown
      1. When?
      2. Where?
    3. For planning operations, budgets, medical services/supplies needed etc:
      1. How large is the real spread of the disease?
      2. What proportion of the population is already immune to the disease?
        1. Infected and recovered
        2. Residual immunity from earlier
      3. When infected, what proportion of the population will be
        1. asymptomatic,
        2. symptomatic (home isolated or quarantined)
        3. symptomatic (hospitalised)
        4. will die

Realism in testing:

  • Clearly one cannot be testing everybody very frequently
  • Testing methods have their own limitations and that should be understood by all: a) the sample has to be collected correctly so as to not miss out the virus due to poor sample collection, b) every test method has some limits of sensitivity and specificity, c) different test methods answer different questions.
  • The test methods which detect the SARS-COV-2 specific  parts of the virus RNA tell you “if the virus RNA is present in detectable concentrations inside you at that time in the location from where the sample was taken“. What are the assumptions here? a) we know exactly which gene is unique to SARS-COV-2, b) virus is present in concentrations above minimum detectable concentration, c) one has chosen the right place to sample from, d) one has collected sample properly so as to not miss the virus.
  • The test methods which detects an antibody that the body has produced in response to the presence of the SARS-COV-2 virus, tell you that “the virus was present in the body at some point and the body responded by producing antibodies to counter it“. What are the assumptions here? a) the antibody being detected is specific to the SARS-COV-2, b) the antibody is not being confused with another one looking similar, c) the antibody is present in concentrations higher than detectable limits, d) the person did not get an external infusion of antibodies or a vaccine causing production of the antibody.

 

  1. (23 March 2020) Compilation of online learning resources for incubator staff Comments Off
  2. (22 March 2020) COVID 19 Perspective Comments Off
  3. (22 March 2020) Making “Work from Home” work (for startups) Comments Off
  4. (16 Dec 2019) Benjamin Franklin method of taking decisions Comments Off
  5. (15 Dec 2019) My wish list for a Pune Knowledge-driven Innovation Cluster Comments Off
  6. (15 Dec 2019) Pune’s Knowledge, Innovation & Industry Clusters Comments Off
  7. (15 Dec 2019) On innovation clusters Comments Off
  8. (26 Oct 2019) What should India’s strategy on indigenous API manufacturing be? Comments Off
  9. (23 Sep 2019) Farewell to Guru Comments Off
  10. (25 Aug 2019) Science, engineering and technology Comments Off
  11. (2 Sep 2019) Disruptive innovation at the interfaces of the drug industry Comments Off
  12. (22 May 2019) Lessons from Sweden in Innovation Management Comments Off
  13. (25 Dec 2018) So you want to be rich? Comments Off
  14. (25 Dec 2018) Pune Startups: Review and Outlook Comments Off
  15. (16 Dec 2018) The Perfect Librarian and “Cool” Lady: Remembering Saroj Krishnaswami Comments Off
  16. (12 Oct 2018) Open Innovation: Excerpts from CII CTO Summit Comments Off
  17. (2 Sep 2018) My memories of my grandfather Comments Off
  18. (11 Aug 2018) Convocation address, Dept of Chem Engg, IIT-Bombay Comments Off
  19. (25 June 2018) Selected reports on startups and VC investments in India Comments Off
  20. (25 June 2018) Selected Readings on Incubation and Acceleration Comments Off
  21. (20 May 2018) Interesting comments in Blink article on Memes Comments Off
  22. (22 April 2018) New book on Med Tech Innovation by Prof Ravi, IIT-Bombay Comments Off
  23. (20 April 2018) Dr Padmanabhan’s new memoir Comments Off
  24. (20 April 2018) Using Rallly for scheduling meetings involving multiple busy people: Comments Off
  25. (21 July 2017) Learning from Ashish Comments Off
  26. (10 June 2017) Mission Admission — A reality check! Comments Off
  27. Excerpts from “Shoe Dog: A memoir by the creator of Nike” by Phil Knight. Comments Off
  28. Defining technology, innovation, entrepreneurship, social entrepreneurship! Comments Off
  29. (2 June 2016) Success is defined by your choices Comments Off
  30. Why do we work? Comments Off
  31. How can startups attract and retain talent? Comments Off
  32. Career development: Growing in responsibilities Comments Off
  33. Tips for writing a Statement of Purpose (SOP) Comments Off
  34. Does poor academic performance in school/college matter to my prospects? Comments Off
  35. Quotes from “I too had a dream”, by Verghese Kurien Comments Off
  36. Tips on writing good resumes Comments Off
  37. How to choose a company name (in India)? Comments Off
  38. Careers in intellectual property in India Comments Off
  39. On social enterprises Comments Off
  40. What is entrepreneurship? Comments Off
  41. How should you choose a place to pursue undergraduate studies? Comments Off
  42. Seeking a job vs seeking excellence Comments Off
  43. How do US universities decide on who to admit for PhD programs and offer scholarships? Comments Off
  44. No absolutes Comments Off
  45. Fire in the belly Comments Off
  46. The curse of versatility Comments Off
  47. The opportunity in front of chemical engineers today Leave a reply
  48. What is Chemical engineering? Leave a reply
  49. What is science? What motivates scientists? Leave a reply
  50. Should you join a PhD program? Leave a reply
  51. Competition and blinders Comments Off
  52. Learning goals for primary school children Comments Off
  53. Launch of the blog Comments Off